26 April 2023 : Clinical Research
Factors Associated with Sarcopenia in Patients with Chronic Kidney Disease: A Cross-Sectional Single-Center Study
Sibel Gulcicek1ABCDEFG*, Nurhan Seyahi2ACEFGDOI: 10.12659/MSM.939457
Med Sci Monit 2023; 29:e939457
Supplementary Table 1 Distribution of current medications used by the patients.
| Current medications | N (%) |
|---|---|
| ACE inhibitors | 63 (28.6) |
| ARBs | 81 (36.8) |
| CCBs | 114 (51.8) |
| Diuretics | 102 (46.4) |
| Alpha-blockers | 23 (10.5) |
| Beta-blockers | 81 (36.8) |
| ASA | 59 (26.8) |
| Allopurinol | 28 (12.7) |
| Insulin | 42 (19.1) |
| Oral antidiabetics | 93 (42.3) |
| Statin | 53 (24.1) |
| Others | 40 (18.2) |
| Total (Median [Min–Max]) | 4 [0–9] |
| Multiple medications (≥4), N(%) | 129 (58.6) |
| ACE – angiotensin-converting enzyme; ARBs – angiotensin receptor blockers; CCBs – calcium channel blockers; ASA – acetylsalicylic acid. | |